HCAT - danger ahead

Telah dikemas kini
The recent Medical-Tech-SaaS IPO had some problems in their S-1 report. I expect it to sink to "below ipo level" as the problems could show up in 1-2 quaters after IPO.
The problem is called "Medicity buyout" and hiding the price of acquision besides the main datasheet in S-1.
Second problem is that it has very slow growth.
Nota
-10%
Dagangan ditutup: sasaran tercapai
now 32
Beyond Technical AnalysisHCATIPOSPDR S&P 500 ETF (SPY)

Juga pada:

Penafian